James Perry
Impact in
Papers in
- Co-authors
- Wolfgang Wick (15 shared papers)Michael Weller (12 shared papers)Normand Laperrière (19 shared papers)Timothy Francis Cloughesy (5 shared papers)Arjun Sahgal (43 shared papers)William H Geerts (2 shared papers)Warren P. Mason (12 shared papers)Nir Lipsman (11 shared papers)
- Journals
- Neuro-Oncology (28 papers)Journal of Neuro-Oncology (12 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (9 papers)The American Journal of Cardiology (6 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
James Perry
201 papers receiving 14.3k citations
James Perry's Hit Papers
Peers
Comparison fields: 5 of 148
- Genetics 5.9k
- Virology 1.2k
- Internal Medicine 509
- Immunology and Allergy 236
- Oncology 857
Countries citing papers authored by James Perry
This map shows the geographic impact of James Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Perry more than expected).
Fields of papers citing papers by James Perry
This network shows the impact of papers produced by James Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Perry. The network helps show where James Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside James Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program Hit paper breakdown → | 2021 | 1363 |
| 2 | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Hit paper breakdown → | 2017 | 938 |
| 3 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2014 | 883 |
| 4 | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma Hit paper breakdown → | 2017 | 879 |
| 5 | Standards of care for treatment of recurrent glioblastoma—are we there yet? Hit paper breakdown → | 2012 | 650 |
| 6 | Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys Hit paper breakdown → | 2013 | 549 |
| 7 | Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study Hit paper breakdown → | 2019 | 518 |
| 8 | Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma Hit paper breakdown → | 2023 | 493 |
| 9 | 2010 | 329 | |
| 10 | 2010 | 304 | |
| 11 | 2015 | 264 | |
| 12 | 2000 | 238 | |
| 13 | 2005 | 235 | |
| 14 | 2015 | 213 | |
| 15 | 2010 | 209 | |
| 16 | Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial Hit paper breakdown → | 2024 | 191 |
| 17 | 2017 | 185 | |
| 18 | 2007 | 174 | |
| 19 | 2016 | 173 | |
| 20 | 2021 | 169 |
About James Perry
James Perry is a scholar working on Genetics, Virology, Internal Medicine, Pulmonary and Respiratory Medicine and Neurology, having authored 206 papers that have together received 14.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (97 papers), HIV Research and Treatment (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Brain Metastases and Treatment (8 papers), Advanced Radiotherapy Techniques (6 papers), Management of metastatic bone disease (5 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Ultrasound and Hyperthermia Applications (5 papers). The work is most often cited by research in Genetics (5.9k citations), Virology (1.2k citations), Internal Medicine (509 citations), Immunology and Allergy (236 citations) and Oncology (857 citations). James Perry has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Wolfgang Wick, Michael Weller, Normand Laperrière, Timothy Francis Cloughesy, Arjun Sahgal, William H Geerts, Warren P. Mason, Nir Lipsman, Alexandra Chambers and Ying Meng. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.